Max Healthcare Institute Limited (BOM:543220)
India flag India · Delayed Price · Currency is INR
997.00
-1.70 (-0.17%)
At close: Aug 21, 2026

Max Healthcare Institute Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
87,12183,73570,28554,06045,62639,366
87,12183,73570,28554,06045,62639,366
Revenue Growth
15.96%19.14%30.01%18.49%15.90%56.96%
Cost of Revenue
32,65431,47126,51120,52917,31417,481
Gross Profit
54,46752,26343,77433,53128,31221,885
Selling, General & Admin
18,91117,94014,74711,1699,8638,729
Other Operating Expenses
12,34611,86810,1577,1595,8873,365
Operating Expenses
35,99734,27428,49920,77818,07214,305
Operating Income
18,47017,99015,27512,75310,2407,580
Interest Expense
-2,312-2,150-1,488-445.6-713.2-900.1
Interest & Investment Income
1,2241,1501,1721,5621,124750.9
Currency Exchange Gain (Loss)
-26.6-26.6-73-2.4-3.4
Other Non Operating Income (Expenses)
180.3213.5204.441.686.7207.3
EBT Excluding Unusual Items
17,53517,17715,15813,91410,7357,634
Merger & Restructuring Charges
-143.4-143.4-736.3---90.3
Gain (Loss) on Sale of Assets
6.56.51.14.513.3-30.6
Asset Writedown
------0.6
Other Unusual Items
-283.8-283.8-358.8-265.4-111.2-123.8
Pretax Income
17,11516,75614,06413,65310,6377,389
Income Tax Expense
2,5412,3323,3053,077-397.91,339
Earnings From Continuing Operations
14,57414,42410,75910,57611,0356,051
Net Income to Company
14,57414,42410,75910,57611,0356,051
Minority Interest in Earnings
-4.7-----
Net Income
14,56914,42410,75910,57611,0356,051
Net Income to Common
14,56914,42410,75910,57611,0356,051
Net Income Growth
26.96%34.07%1.73%-4.16%82.38%-
Shares Outstanding (Basic)
972972972972970967
Shares Outstanding (Diluted)
977977977975972969
Shares Change
-0.05%-0.00%0.20%0.39%0.24%12.30%
EPS (Basic)
14.9814.8311.0710.8911.386.25
EPS (Diluted)
14.9114.7611.0110.8411.366.24
EPS Growth
27.01%34.06%1.57%-4.58%82.05%-

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-1,4884,9353,3579,4851,872
Free Cash Flow Per Share
-1.525.053.449.761.93
Dividend Per Share
-2.0001.5001.5001.000-
Dividend Growth
-33.33%0%50.00%--
Gross Margin
62.52%62.41%62.28%62.02%62.05%55.59%
Operating Margin
21.20%21.48%21.73%23.59%22.44%19.25%
Profit Margin
16.72%17.23%15.31%19.56%24.19%15.37%
Free Cash Flow Margin
-1.78%7.02%6.21%20.79%4.75%
EBITDA
22,45821,78818,31214,81912,2269,465
EBITDA Margin
25.78%26.02%26.05%27.41%26.80%24.04%
D&A For EBITDA
3,9883,7983,0372,0661,9861,886
EBIT
18,47017,99015,27512,75310,2407,580
EBIT Margin
21.20%21.48%21.73%23.59%22.44%19.25%
Effective Tax Rate
14.85%13.92%23.50%22.54%-18.12%
Revenue as Reported
88,78785,36171,84155,83047,01840,588
Advertising Expenses
-----446.2